Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Miyasaka, N

Class:IdPerson:8950042
_displayNameMiyasaka, N
_timestamp2016-12-02 10:58:24
created[InstanceEdit:8950071] Duenas, Corina, 2016-12-02
firstnameN
initialN
surnameMiyasaka
(author)[LiteratureReference:9024724] Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion
[LiteratureReference:9024736] CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling
[LiteratureReference:9027126] Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3
[LiteratureReference:9027182] Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway
[LiteratureReference:9027195] Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells
[Change default viewing format]
No pathways have been reviewed or authored by Miyasaka, N (8950042)